Vimarsana
Biggest News Aggregation in the World

Karan Verma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Karan Verma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Karan Verma Today - Breaking & Trending Today

Novo Nordisk braces for generic challenge to Ozempic, Wegovy in China - Vimarsana News

Novo Nordisk braces for generic challenge to Ozempic, Wegovy in China

By Andrew Silver SHANGHAI (Reuters) - Novo Nordisk is facing the prospect of intensifying competition in the promising Chinese market where drugmakers are developing at least 15 generic versions of its diabetes drug Ozempic and weight loss treatmen...

Source: kelo.com
Novo Nordisk braces for generic challenge to Ozempic, Wegovy in China - Vimarsana News

Novo Nordisk braces for generic challenge to Ozempic, Wegovy in China

Novo Nordisk is facing the prospect of intensifying competition in the promising Chinese market where drugmakers are developing at least 15 generic versions of its diabetes drug Ozempic and weight...

Novo Nordisk braces for generic challenge to Ozempic, Wegovy in China - Vimarsana News

Novo Nordisk braces for generic challenge to Ozempic, Wegovy in China

SHANGHAI (Reuters) -Novo Nordisk is facing the prospect of intensifying competition in the promising Chinese market where drugmakers are developing at least 15 generic versions of its diabetes drug Ozempic and weight loss treatment Wegovy, clinical trial records showed. The Danish drugmaker has high hopes that demand for its blockbuster drugs will surge in China, which is estimated to have the world's highest number of people who are overweight or obese. Ozempic won approval from China in 2021 and Novo Nordisk saw sales of the drug in the greater China region double to 4.8 billion Danis...

Source: yahoo.com
Novo Nordisk braces for generic challenge to Ozempic, Wegovy in China - Vimarsana News

Novo Nordisk braces for generic challenge to Ozempic, Wegovy in China

SHANGHAI (Reuters) -Novo Nordisk is facing the prospect of intensifying competition in the promising Chinese market where drugmakers are developing at least 15 generic versions of its diabetes drug Ozempic and weight loss treatment Wegovy, clinical trial records showed. The Danish drugmaker has high hopes that demand for its blockbuster drugs will surge in China, which is estimated to have the world's highest number of people who are overweight or obese. Ozempic won approval from China in 2021 and Novo Nordisk saw sales of the drug in the greater China region double to 4.8 billion Danis...

Source: yahoo.com
Truecaller Launches Chhota SMS Campaign Featuring "Jordindians" - Vimarsana News

Truecaller Launches Chhota SMS Campaign Featuring "Jordindians"

Truecaller Launches Chhota SMS Campaign Featuring “Jordindians” : Rashtra News Truecaller, the leading global platform for verifying contacts and blocking unwanted communications, launches the Chhota SMS Campaign, starring the Jordindians playing Aman and Chaman. The campaign has been designed in line with Truecallers objective of making communication smarter and highlights how one of the characters